Can a stronger jolt to the brain beat treatment-resistant depression?
NCT ID NCT02942368
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small pilot study tested a noninvasive brain stimulation technique called tDCS in 5 adults with major depression that hadn't improved after at least 3 antidepressant trials. Participants received up to 20 sessions of higher-than-usual electrical current over 4 to 6 weeks. The study was terminated early, so the results are very limited and not conclusive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS) device
- What this could lead to
- If it works, this could point toward a non-drug option for people with depression that hasn't responded to multiple medications.
- What could go wrong
- This was a very small pilot study with only 5 participants and it was terminated early. Higher doses may cause side effects, and the approach is still highly experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University in Saint Louis
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-Day brain zaps: a new hope for stubborn depression?
- Nasal spray could offer new hope for Treatment-Resistant depression
- Experimental depression drug aims to help when standard meds fail
- Which works best for stubborn depression? adding a drug, brain stimulation, or switching meds?
- Fast brain stimulation shows promise for stubborn depression
- Ketamine booster for shock therapy? new trial aims to lift depression and protect memory